A new study reveals that changes in gut microbial load, influenced by factors like diet, age, and antibiotics, drive the presence of bacteria previously linked to diseases such as inflammatory bowel ...
P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...
One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.
CNN also spoke with Dr. Farah Monzur, an assistant professor of medicine and director of the Inflammatory Bowel Disease ...
Microorganisms—bacteria, viruses and other tiny life forms—may drive biological variation in visible life as much, if not ...
Thetis Pharmaceuticals, LLC ("Thetis"), a pharmaceutical company developing an oral, small molecule Resolvin E1 (RvE1) drug targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) and ...
Dr. Farah Monzur, an assistant professor of medicine and director of the Inflammatory Bowel Disease Center at Stony Brook ...
The first patient has been dosed in Microbiotica’s Phase 1b first-in-human trial, COMPOSER-1, of MB310.
What begins as a quick three-minute bathroom break often turns into 15 minutes of scrolling, reading, and posting—a familiar ...
According to Dr. Farah Monzur from Stony Brook Medicine, people should limit toilet time to 5-10 minutes to avoid issues.
multiple sclerosis and inflammatory bowel disease (IBD). Though links have been drawn between these microbes and the ...
Millions of Malaysians aren’t aware that a huge list of health problems —both mental and physical — can be directly linked to the state of their gut health.